Ansan, South Korea

Kang Sik Seo

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignee: Curome Biosciences Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kang Sik Seo. Retrieved from https://idiyas.com/inventor/kang-sik-seo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kang Sik Seo in Pharmaceutical Composition

Introduction

Kang Sik Seo is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Kang Sik Seo holds a patent for a pharmaceutical composition containing β-lapachone as an active ingredient for the prevention or treatment of cholestatic liver disease. This invention provides an effective agent for preventing and treating this serious condition, showcasing his commitment to advancing medical science.

Career Highlights

Kang Sik Seo is associated with Curome Biosciences Co., Ltd., where he continues to develop groundbreaking pharmaceutical solutions. His expertise and dedication have positioned him as a key figure in the industry.

Collaborations

He collaborates with talented professionals such as Joo Seog Yoon and Jeong Su Han, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kang Sik Seo's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions are vital for the advancement of treatments for liver diseases, and his ongoing research promises to yield further breakthroughs in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…